[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ATOS":3,"homepage-market-summary":29,"stock-stats-ATOS":170},{"ticker":4,"date":5,"profile":6,"quote":14},"ATOS","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Atossa Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM\u002FSERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.","14","Seattle, WA",{"close":15,"open":16,"high":17,"low":16,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},2.27,1.96,2.3,1.95,0.32,16.41,112714.52742,903,2.1416,33480,1.7,105080.50086820436,0,3494,{"status":30,"indices":31,"watchlist":73,"sectors":96,"benchmarks":150},"success",[32,40,47,54,60,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":52,"is_up":38,"sparkline":59,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":45,"is_up":38,"sparkline":72,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[74,81,89],{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":38,"sparkline":80,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":87,"sparkline":88,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":87,"sparkline":95,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[97,102,107,112,117,122,126,131,135,140,145],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",1.05,197.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.11,53.46,{"name":108,"etf":109,"change":110,"price":111,"is_up":87},"Healthcare","XLV",-1.32,166.2,{"name":113,"etf":114,"change":115,"price":116,"is_up":87},"Consumer Cycl","XLY",-0.03,108.81,{"name":118,"etf":119,"change":120,"price":121,"is_up":87},"Consumer Staples","XLP",-0.33,80.33,{"name":123,"etf":124,"change":18,"price":125,"is_up":38},"Energy","XLE",62.7,{"name":127,"etf":128,"change":129,"price":130,"is_up":38},"Industrials","XLI",0.99,168.64,{"name":132,"etf":133,"change":120,"price":134,"is_up":87},"Materials","XLB",48.54,{"name":136,"etf":137,"change":138,"price":139,"is_up":87},"Real Estate","XLRE",-0.56,40.68,{"name":141,"etf":142,"change":143,"price":144,"is_up":38},"Utilities","XLU",0.61,39.68,{"name":146,"etf":147,"change":148,"price":149,"is_up":87},"Comm Services","XLC",-0.93,109.94,[151,156,160,165],{"ticker":152,"name":153,"price":154,"change":155,"is_up":38},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":157,"name":158,"price":159,"change":45,"is_up":38},"QQQ","Invesco QQQ Trust",742.03,{"ticker":161,"name":162,"price":163,"change":164,"is_up":38},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":166,"name":167,"price":168,"change":169,"is_up":38},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"company_name":7,"current_price":15,"data_notice":171,"valuation":172,"dates":175,"share_statistics":178,"valuation_ratios":181,"enterprise_valuation":183,"financial_position":184,"financial_efficiency":187,"taxes":192,"price_statistics":193,"income_statement":200,"balance_sheet":206,"cash_flow":212,"margins":217,"dividends":218,"analyst_forecast":221,"fair_value":223,"splits":225},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":173,"enterprise_value":9,"summary":174},18960666.2,"ATOS has a market cap of $18,960,666.20.",{"latest_fiscal_period_end":176,"earnings_date":9,"ex_dividend_date":9,"summary":177},"2026-03-31","Most recent reported fiscal period end: 2026-03-31.",{"shares_outstanding":179,"owned_by_insiders":9,"owned_by_institutions":9,"summary":180},9979298,"ATOS has 9,979,298 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":182,"pfcf_ratio":9,"pocf_ratio":9},0.74,{"ev_earnings":9,"ev_sales":9,"ev_ebitda":9,"ev_ebit":9,"ev_fcf":9},{"current_ratio":185,"debt_equity":9,"debt_ebitda":9,"debt_fcf":9,"summary":186},4.92,"The company has a current ratio of 4.92.",{"roe":188,"roa":189,"revenue_per_employee":9,"profit_per_employee":190,"employee_count":191,"asset_turnover":9},-31.45,-25.27,-684929,14,{"income_tax":27},{"beta_5y":9,"price_change_52w":194,"ma_50":195,"ma_200":196,"rsi_14":197,"avg_volume_20d":198,"summary":199},-83.55,2.38,4.73,40.32,61104,"The stock price has changed by -83.55% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":201,"pretax_income":202,"net_income":202,"ebitda":203,"ebit":201,"eps":204,"summary":205},-9870000,-9589000,-9866000,-1.11,"Income statement data is not available for this symbol.",{"cash_and_equiv":207,"total_debt":9,"net_cash":9,"net_cash_per_share":9,"equity_book_value":208,"book_value_per_share":209,"working_capital":210,"summary":211},31718000,30486000,3.05,29211000,"Balance sheet data is not available for this symbol.",{"operating_cash_flow":213,"capital_expenditures":27,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":214,"fcf_per_share":215,"summary":216},-10450000,-9581000,-0.96,"Free cash flow was $-9,581,000.00.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":219,"summary":220},-50.53,"ATOS has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":222},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":224},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":226},"Stock split history is not available for this symbol."]